RxDoctor Payments Data

Jodie McIlvain, PA

Physician Assistant · Billings, MTNPI 1720623861

Payments from drug & device makers

$872in general payments, 2019–2025

Across 12 payments — averaging $72.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$174
  • Dexcom, Inc.$173
  • Sanofi-aventis U.S. LLC$156
  • Abbott$145
  • Insulet Corporation$109
  • Corcept Therapeutics$54
  • plus $61 from 3 others

What the payments were for

  • Travel & lodging$202%
  • Food & beverage$81593%
  • Education$374%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$872 in reported general payments places this provider in the 85th percentile of 626 physician assistant providers in Montana.

See all physician assistant providers in Montana

Medicare billing

Part B allowed, 2024
$52,293
Medicare patients
131
Services billed
933

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide194$320,901
OzempicSemaglutide108$168,237
JardianceEmpagliflozin113$140,807
TrulicityDulaglutide88$130,392
Tresiba Flextouch U-200Insulin Degludec53$77,197
Tresiba Flextouch U-100Insulin Degludec55$44,586
FarxigaDapagliflozin Propanediol37$41,989
Fiasp FlextouchInsulin Aspart (Niacinamide)22$39,188
Novolog FlexpenInsulin Aspart92$33,279
Lyumjev Kwikpen U-100Insulin Lispro-Aabc26$31,710
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog28$31,414
Humalog Kwikpen U-100Insulin Lispro60$30,782
Humulin R U-500 KwikpenInsulin Regular, Human25$28,135
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog37$25,198
RybelsusSemaglutide18$24,762

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro$12$462,901336 claims
Novo NordiskOzempic, Rybelsus, Novolog$26$199,676153 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 626 physician assistant providers in Montana.

Other physician assistant in Billings

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →